Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch

Jingfeng Wang1, Zhenning Nie1, Haiyan Chen2

  • 1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University.

Insights

Researchers developed a new canine model for heart failure with left bundle branch block to study cardiac resynchronization therapy. This model shows CRT effectively reverses heart dysfunction and remodeling.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Animal Models

Background:

  • Left bundle branch block (LBBB) predicts significant benefits from cardiac resynchronization therapy (CRT) in heart failure (HF) patients.
  • Existing HF models lack stable LBBB and show rapid reversal of left ventricular (LV) dysfunction, limiting CRT research.

Purpose of the Study:

  • To establish a chronic, stable canine model of asynchronous HF with isolated LBBB for studying CRT.
  • To validate the model's suitability for assessing CRT's structural and biological reverse remodeling effects.

Main Methods:

  • Induction of asynchronous HF via left bundle branch (LBB) ablation and 4 weeks of rapid right ventricular (RV) pacing in canines.
  • Implantation of pacing leads for CRT and use of radiofrequency (RF) catheter ablation.
  • Validation using 2D speckle tracking imaging and aortic velocity time integral (aVTI) to assess LV asynchrony and CRT efficacy.

Main Results:

  • Successful establishment of a chronic, stable HF model with LV asynchrony.
  • CRT demonstrated effectiveness in coordinating ventricular activation, improving LV pump function, and reversing LV dilation.
  • Histopathological analysis revealed CRT-induced reverse remodeling, including restored cardiomyocyte diameter and collagen volume fraction (CVF).

Conclusions:

  • A feasible and valid method for developing a chronic asynchronous HF model with LBBB was established.
  • This model is suitable for investigating the structural and biological reverse remodeling induced by CRT.
  • The model provides a platform for further research into CRT mechanisms and optimization.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
787
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K